Výsledky vyhľadávania
Titul Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (doxetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer Titul PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer Titul Protinádorová liečba u pacientov s renálnou insuficienciou